Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about Brenzys.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the risks of you taking Brenzys against the benefits this medicine
is expected to have for you.
If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Keep this leaflet with the medicine.
You may need to read it again.
What Brenzys is used for
Brenzys is used in adults for the treatment of:
non-radiographic axial spondyloarthritis (nr-AxSpA)
Tumour necrosis factor (TNF) is a naturally occurring chemical messenger in your bloodstream. TNF plays a role in causing
pain and swelling in the joints. Brenzys is a biotechnology-derived protein that works by binding to TNF and preventing it
from acting. This reduces the pain and swelling of rheumatoid arthritis and psoriasis, helps to treat the skin lesions of
psoriasis and psoriatic arthritis, and improves the condition of patients with ankylosing spondylitis and nr-AxSpA.
Your doctor may have prescribed Brenzys for another reason. Ask your doctor if you have any questions about why Brenzys has
been prescribed for you.
This medicine is available only with a doctor's prescription.
Brenzys is not addictive.
Brenzys is not indicated for use in children less than 18 years of age. Other etanercept products are available for use in
Before you use Brenzys
When you must not use it
Do not use Brenzys if:
1.You have an allergy to Brenzys or any of the ingredients listed at the end of this leaflet.
Symptoms of an allergic reaction may include wheezing, shortness of breath, difficulty breathing, or a tight feeling in your
chest, swelling of the face, lips, tongue or other parts of the body, rash, itching, hives or flushed red skin, dizziness
2.You have, or are at risk of developing, sepsis (blood poisoning), or long-term or localised infection (for example, leg ulcer).
Sepsis is a serious infection causing fever, headache, joint aches and pains, sore or weak muscles, and increased heart rate.
Brenzys can affect your body's ability to fight a serious infection.
If you are not sure whether you have a serious infection, check with your doctor.
3.You are currently taking anakinra or other similar medicines known as Interleukin-1 antagonists, or other biological medicines
such as anti-TNF drugs, tocilizumab or abatacept.
4.The packaging is torn or shows signs of tampering.
5.The expiry date (EXP) printed on the pack has passed.
If you use Brenzys after the expiry date has passed, it may have no effect at all, or worse, have an entirely unexpected effect.
If you are not sure whether you should start using Brenzys, contact your doctor.
Before you use it
Tell your doctor if:
1.You have any allergies to:
Any other medicines
Any other substances, such as foods, preservatives or dyes.
2.You are pregnant or intend to become pregnant.
The effects of Brenzys in pregnant women are not well understood, therefore the use of Brenzys is not recommended during pregnancy.
Women of childbearing age are advised to use contraception to avoid falling pregnant. If you become pregnant while using Brenzys,
contact your doctor.
3.You are breast-feeding or plan to breast-feed.
It is not known whether Brenzys passes through breast milk. Therefore, if you are breast-feeding, you should discuss with
your doctor whether to stop breast-feeding or stop using Brenzys.
4.You have or have had any other medical conditions, especially the following:
Serious infection including sepsis, tuberculosis or a history of recurring infections
Low resistance to disease
Liver problems or hepatitis B or hepatitis C, viruses that affect the liver
Are about to have major surgery
Nerve disorders including multiple sclerosis or optic neuritis (inflammation of the nerves of the eyes)
Chicken pox or have been recently exposed to chickenpox.
Live vaccines, such as oral polio vaccine, should not be given while receiving Brenzys.
Ensure that children are up to date with all vaccinations (including chicken pox) before they start treatment with etanercept.
If you have not told your doctor about any of the above, tell them before you start using Brenzys.
Taking other medicines
Tell your doctor if you are taking any other medicines, including any that you buy without a prescription from your pharmacy,
supermarket or health food shop.
Some medicines may affect the way others work. Your doctor or pharmacist will be able to tell you what to do when using Brenzys
with other medicines. Brenzys may interact with other medicines such as:
Abatacept, sulfasalazine or Interleukin-1 antagonists such as anakinra. These medicines are used to treat rheumatoid arthritis
and other inflammatory diseases
Cyclophosphamide, a medicine used to treat cancer or prevent transplant rejection
Digoxin, a medicine used to improve the strength and efficiency of the heart, or to control the rate and rhythm of the heartbeat
Warfarin, a medicine used to thin the blood and prevent blood clots
Medicines used to treat diabetes.
How to use Brenzys
After allowing the Brenzys syringe or Auto-injector to reach room temperature (approximately 30 minutes), immediate use is
Each syringe or Auto-injector of Brenzys is for single use only, in one patient only. Discard any residue.
Follow all directions given to you by your doctor and pharmacist carefully.
They may differ from the information contained in this leaflet.
If you are injecting Brenzys yourself, you must follow the detailed instructions provided in the leaflet inside the pack.
Brenzys is injected under the skin. When using the syringes, it is important that you do not pull back on the plunger. Brenzys
can be injected by your doctor, nurse, carer or by yourself.
When you have finished injecting Brenzys, discard the syringe or Auto-injector into a sharps container.
If you do not understand the instructions for injecting Brenzys found in the carton, ask your doctor or pharmacist for help.
To help you remember, use a diary to write in the days of the week you should have an Brenzys injection.
How much to use
Your doctor will tell you how to inject Brenzys. A different site should be used for each new injection. Each new injection
should be given at least 3cm from an old site.
The recommended dose for adults is 50 mg per week, injected under the skin. Your doctor may determine a different frequency
at which to inject Brenzys. If you are being treated for psoriasis, your doctor may prescribe a higher dose of Brenzys when
you first begin your treatment. If you are being treated for nr-AxSpA and Brenzys has no effect on your condition within 12
weeks, your doctor may tell you to stop using this medicine.
Brenzys is not indicated for use in children less than 18 years of age. Other etanercept products are available for use in
How long to take it
You should continue to inject Brenzys for as long as your doctor recommends.
Never inject more than the dose recommended by your doctor.
If you feel that the effect of Brenzys is too strong or too weak, talk to your doctor or pharmacist.
If you forget to take it
If you forget to give yourself an injection, you should inject the next dose as soon as you remember if it is within 48 hours
since the scheduled dose time. If it is more than 48 hours since the last dose was due, wait for the next scheduled dose.
Do not use a double dose to make up for the dose that you missed. If you are not sure what to do, ask your doctor or pharmacist.
If you have trouble remembering to use your medicine, ask your pharmacist for some hints.
If you take too much (overdose)
Immediately telephone your doctor or the Poisons Information Centre (in Australia; tel 13 11 26), or go to Accident and Emergency
at your nearest hospital, if you think that you or anyone else may have used too much Brenzys. Do this even if there are no
signs of discomfort or poisoning. Always take the labelled medicine carton with you, even if it is empty.
You may need urgent medical attention. There is very limited data on overdose with Brenzys. Ask your doctor if you have any
While you are using Brenzys
Things you must do
Tell any other doctors, dentists and pharmacists who are treating you that you are using Brenzys.
Tell your doctor if Brenzys is not making your condition better.
If you have or develop any serious infection while using Brenzys, do not inject any more Brenzys and contact your doctor immediately.
Seek medical advice immediately if you have any symptoms such as persistent fever, sore throat, bruising, bleeding or paleness.
These symptoms may point to the existence of a potentially life threatening blood disorder, which may require you to stop
Be careful driving or operating dangerous machinery until you know how it affects you.
It is not known whether Brenzys causes dizziness or drowsiness.
Things you must not do
Do not shake the Brenzys syringe or Auto-injector.
Do not give Brenzys to anyone else even if they have the same condition as you.
Do not use Brenzys to treat any other complaints unless your doctor tells you to.
Do not stop using Brenzys, or lower the dosage, without checking with your doctor.
Do not stop using Brenzys because you are feeling better, unless your doctor advises you to.
Your condition may flare up if you reduce the dose or stop using Brenzys.
Check with your doctor as soon as possible if you have any problems while taking Brenzys, even if you do not think the problems
are connected with the medicine or are not listed in this leaflet.
Like other medicines, Brenzys can cause some side effects. If they occur, most are likely to be minor and temporary. However,
some may be serious and need medical attention. The most common side effects with Brenzys are injection site reactions, infections,
allergic reactions, itching, and fever. Please see below for more detail.
Ask your doctor or pharmacist to answer any questions you may have.
Injection site reactions
The most common side effect is a mild reaction in the area where Brenzys was injected, including:
Bleeding, swelling, pain or hardness around the injection site.
These reactions generally do not occur as often after the first month of treatment.
If you are concerned about injection site reactions, contact your doctor or pharmacist.
When injecting Brenzys, some people have developed a reaction to an injection site used before.
Infections, including colds and sinus infections, are very common.
Serious infections may occur including tuberculosis and blood poisoning.
Tell your doctor immediately if you notice any of the following:
Signs of an infection such as fever, chills, mouth ulcers or sore throat
Signs of lung disease such as breathlessness during exercise or a dry cough
Signs of soft tissue infections such as bumps or sores that do not heal, are swollen, red or have pus
Signs of nervous system disorders such as seizures, numbness or tingling throughout your body, weakness in your arms and/or
legs and dizziness, or problems with your eye sight
Inflammation of the spinal cord
Inflammation of the inner eye
Inflammation of blood vessels in the skin or lymph glands
Diarrhoea or mucus or blood in your stools
Signs of an allergic reaction such as swelling of the face, lips or tongue which may cause difficulty in swallowing or breathing,
Signs of lupus or lupus-like syndrome, such as weight changes, persistent rash, fever, joint or muscle pain, or fatigue
Other signs of immune system disorders such as skin rash, blisters and ulcers on the skin, in the mouth or airways
Signs of a blood disorder such as tiredness, headaches, shortness of breath when exercising, dizziness, paleness, nose bleeds,
unusual bleeding or bruising or more frequent infections
Worsening of existing heart failure
These may be very serious side effects. You may need urgent medical attention or hospitalisation. These side effects are rare.
Other side effects not listed above may also occur in some patients. Tell your doctor if you notice anything else that is
making you unwell.
There have been reports of some types of cancer developing in patients using Brenzys and other TNF blocking medicines. These
include skin cancers, cancers that affect the lymph system called lymphoma, or affect the blood system called leukaemia. The
role of Brenzys in the development of cancer is not known.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
After using Brenzys
Keep Brenzys where children cannot reach it.
Keep Brenzys in a refrigerator where the temperature stays between 2°C and 8°C. Do not freeze. Do not store Brenzys or any
other medicine in the bathroom or near a sink. Do not leave it in the car or on window sills. Brenzys syringes and Auto-injectors
should be stored in their cartons to protect them from light.
Heat and dampness can destroy some medicines.
If it is not possible to store Brenzys in the refrigerator, it may be stored out of the refrigerator (below 25°C) for up to
4 weeks (e.g. when travelling). Do not use Brenzys if it has been exposed to high temperatures, or has been out of the refrigerator
for more than 4 weeks.
Ask your pharmacist how to dispose of medicines no longer required.
What it looks like
Pre-filled Syringe (Solution for injection):
Brenzys Pre-filled Syringe is supplied in a carton containing four single-use pre-filled glass syringes containing Brenzys
solution. Each syringe contains 50 mg of etanercept in 1 mL of Brenzys solution.
Auto-injector (Solution for injection)
The Brenzys Auto-injector is supplied in a carton containing either one or four single-use pre-filled glass syringes, each
housed in a plastic Auto-injector. Each syringe contains 50 mg of etanercept in 1 mL of Brenzys solution.
Solution for injection:
Brenzys solution for injection contains 50 mg of the active ingredient etanercept (rch). The Brenzys solution also contains
sucrose, sodium chloride, sodium phosphate monobasic monohydrate, sodium phosphate dibasic (heptahydrate) and water.
Brenzys is supplied by:
SAMSUNG BIOEPIS AU PTY LTD
Level 16, 201 Elizabeth Street,
Sydney NSW 2000, Australia
Merck Sharp & Dohme (Australia) Pty Limited
Level 1, Building A, 26 Talavera Road
Macquarie Park NSW 2113, Australia
Date of preparation
This leaflet was prepared in January 2017.
® Registered Trademark